| Muhammad Omar Saleem, | |
|
209 N 7th St, Bismarck, ND 58501-4441 | |
| (701) 323-5590 | |
| (701) 323-8109 |
| Full Name | Muhammad Omar Saleem |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 14 Years |
| Location | 209 N 7th St, Bismarck, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598118820 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Jamestown Dialysis | Jamestown, ND | Dialysis facility |
| Sanford Medical Center Bismarck | Bismarck, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Bismarck | 9739098575 | 448 |
News Archive
MEDfx Corporation today announced a Direct Project pilot that demonstrates health information exchange among providers using a combination of the standards and protocols supported by the Direct Project and the FHA CONNECT Gateway. MEDfx is participating in, and is a contributor to, the nationally-sponsored Direct Project under the Office of the National Coordinator of Health IT.
Acsis, Inc., a leader in supply chain visibility and traceability for manufacturing and distribution, today announced that it has been recognized as a 2010 "Top Preferred Solution Provider" by LogiPharma. The company was selected based on a survey by World Business Research (WBR) to more than 2,000 pharmaceutical executives who identified Acsis, Inc. as one of the top solution providers focused on advancing supply chain efficiencies.
Novartis today announced it has entered into a clinical research collaboration in which Bristol-Myers Squibb will investigate the safety, tolerability, and efficacy of Mekinist (trametinib) in combination with Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen as a potential treatment option for metastatic colorectal cancer in patients with microsatellite stable tumors where the tumors are proficient in mismatch repair (MSS mCRC pMMR).
Stress and urgency incontinence are the two most frequent and the most bothersome urinary symptoms among women. It has been estimated that about twelve percent of women report significant bother from stress incontinence and eight percent from urgency incontinence. Urinary incontinence affects hundreds of millions of women worldwide.
Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.
› Verified 2 days ago
| Entity Name | Sanford Bismarck |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811941172 PECOS PAC ID: 9739098575 Enrollment ID: O20031105000403 |
News Archive
MEDfx Corporation today announced a Direct Project pilot that demonstrates health information exchange among providers using a combination of the standards and protocols supported by the Direct Project and the FHA CONNECT Gateway. MEDfx is participating in, and is a contributor to, the nationally-sponsored Direct Project under the Office of the National Coordinator of Health IT.
Acsis, Inc., a leader in supply chain visibility and traceability for manufacturing and distribution, today announced that it has been recognized as a 2010 "Top Preferred Solution Provider" by LogiPharma. The company was selected based on a survey by World Business Research (WBR) to more than 2,000 pharmaceutical executives who identified Acsis, Inc. as one of the top solution providers focused on advancing supply chain efficiencies.
Novartis today announced it has entered into a clinical research collaboration in which Bristol-Myers Squibb will investigate the safety, tolerability, and efficacy of Mekinist (trametinib) in combination with Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen as a potential treatment option for metastatic colorectal cancer in patients with microsatellite stable tumors where the tumors are proficient in mismatch repair (MSS mCRC pMMR).
Stress and urgency incontinence are the two most frequent and the most bothersome urinary symptoms among women. It has been estimated that about twelve percent of women report significant bother from stress incontinence and eight percent from urgency incontinence. Urinary incontinence affects hundreds of millions of women worldwide.
Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Muhammad Omar Saleem, Po Box 5074, Sioux Falls, SD 57117-5074 Ph: (605) 328-6585 | Muhammad Omar Saleem, 209 N 7th St, Bismarck, ND 58501-4441 Ph: (701) 323-5590 |
News Archive
MEDfx Corporation today announced a Direct Project pilot that demonstrates health information exchange among providers using a combination of the standards and protocols supported by the Direct Project and the FHA CONNECT Gateway. MEDfx is participating in, and is a contributor to, the nationally-sponsored Direct Project under the Office of the National Coordinator of Health IT.
Acsis, Inc., a leader in supply chain visibility and traceability for manufacturing and distribution, today announced that it has been recognized as a 2010 "Top Preferred Solution Provider" by LogiPharma. The company was selected based on a survey by World Business Research (WBR) to more than 2,000 pharmaceutical executives who identified Acsis, Inc. as one of the top solution providers focused on advancing supply chain efficiencies.
Novartis today announced it has entered into a clinical research collaboration in which Bristol-Myers Squibb will investigate the safety, tolerability, and efficacy of Mekinist (trametinib) in combination with Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen as a potential treatment option for metastatic colorectal cancer in patients with microsatellite stable tumors where the tumors are proficient in mismatch repair (MSS mCRC pMMR).
Stress and urgency incontinence are the two most frequent and the most bothersome urinary symptoms among women. It has been estimated that about twelve percent of women report significant bother from stress incontinence and eight percent from urgency incontinence. Urinary incontinence affects hundreds of millions of women worldwide.
Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.
› Verified 2 days ago
Dr. Ling Sing Chow, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000 | |
Nicholas C Mahr, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 310 N 10th Street, Bismarck, ND 58501 Phone: 701-530-7500 Fax: 701-530-7484 | |
Dr. Maria Susana Castejon Welchez, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 | |
Dr. Sharmaine Habib, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-8121 | |
Agnieszka Olga Solberg, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000 | |
Amy Marie Kaminski, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000 | |
Ivaldo A Lunardi, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5709 |